These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 54620)

  • 1. Letter: Do changes in blood levels of other aromatic aminoacids influence levodopa therapy?
    Daniel PM; Moorhouse RS; Pratt OE
    Lancet; 1976 Jan; 1(7950):95. PubMed ID: 54620
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa.
    Nutt JG; Woodward WR; Carter JH; Trotman TL
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):481-7. PubMed ID: 2738591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain.
    Daniel PM; Moorhouse SR; Pratt OE
    Psychol Med; 1976 May; 6(2):277-86. PubMed ID: 12522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a controlled low-protein diet on the pharmacological response to levodopa and on the plasma levels of L-dopa and amino acids in patients with Parkinson's disease].
    Sanchís G; Mena MA; Martín del Río R; Morales B; Casarejo MJ; de Yébenes MJ; Tabernero C; Jiménez A; de Yébenes JG
    Arch Neurobiol (Madr); 1991; 54(6):296-302. PubMed ID: 1811460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-O-methyldopa and the response to levodopa in Parkinson's disease.
    Nutt JG; Woodward WR; Gancher ST; Merrick D
    Ann Neurol; 1987 Jun; 21(6):584-8. PubMed ID: 3606046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses.
    Woodward WR; Olanow CW; Beckner RM; Hauser RA; Gauger LL; Cedarbaum JM; Nutt JG
    Neurology; 1993 Sep; 43(9):1704-8. PubMed ID: 8414016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Plasma neutral aminoacids and tryptophan in cirrhosis.
    Munro HN; Fernstrom JD; Wurtman RJ
    Lancet; 1975 Aug; 2(7931):419. PubMed ID: 51234
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of aromatic amino acids by ion-pair reversed-phase liquid chromatography in human sera from healthy and phenylketonuric individuals.
    Kalghatgi K; Ambrus CM; Horvath C; Karakousis CP; Sharma SD; Barren E
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):253-9. PubMed ID: 6484311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amino acids in attention deficit disorder.
    Bornstein RA; Baker GB; Carroll A; King G; Wong JT; Douglass AB
    Psychiatry Res; 1990 Sep; 33(3):301-6. PubMed ID: 2243904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting levodopa effects in Parkinson's disease.
    Ogawa N
    Acta Med Okayama; 2000 Jun; 54(3):95-101. PubMed ID: 10925733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics.
    Nutt JG
    Ann Neurol; 1987 Oct; 22(4):535-40. PubMed ID: 3324948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delirium after cardiac surgery. The possible role of tryptophan in relation to the other neutral aminoacids.
    van der Mast RC; van den Broek WW; Fekkes D; Pepplinkhuizen L; Roest FH
    Adv Exp Med Biol; 1996; 398():93-6. PubMed ID: 8906247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of free amino acids in the blood of leukemia patients following amino acid infusion].
    Stacher A; Stöckl W; Zacherl MK; Weiser M
    Wien Med Wochenschr; 1968 Nov; 118(48):1032-40. PubMed ID: 5250545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amino acid levels in the blood serum of patients with chronic colitis].
    Smagin VG; Asafov GB; Ekisenina NI; Ivanova LM; Lumel'skiĭ VIa
    Ter Arkh; 1974; 46(4):141-7. PubMed ID: 4428362
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Oxprenolol and levodopa in parkinsonian patients.
    Sandler M; Fellows LE; Calne DB; Findley LJ
    Lancet; 1975 Jan; 1(7899):168. PubMed ID: 46086
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Parkinsonism and dementia: effects of levodopa.
    Rajput AH; Rozdilsky B
    Lancet; 1975 May; 1(7915):1084. PubMed ID: 48746
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood-brain transport of tryptophan and phenylalanine: effect of portacaval shunt in dogs.
    Huet PM; Pomier-Layrargues G; Duguay L; du Souich P
    Am J Physiol; 1981 Aug; 241(2):G163-9. PubMed ID: 7270694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Acta Med Scand; 1974 Dec; 196(6):459-63. PubMed ID: 4456974
    [No Abstract]   [Full Text] [Related]  

  • 19. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.
    Nutt JG; Woodward WR; Hammerstad JP; Carter JH; Anderson JL
    N Engl J Med; 1984 Feb; 310(8):483-8. PubMed ID: 6694694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
    Rappelli A; Glorioso N; Tedde R; Dessi'-Fulgheri P; Monaco F
    J Neurol Neurosurg Psychiatry; 1978 Oct; 41(10):915-8. PubMed ID: 731241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.